Early detection and management of neurological serious adverse events in relation to the administration of anthelminthic medicines to people with asymptomatic neurocysticercosis
Author: World Health Organization
Publisher: World Health Organization
Published: 2023-09-18
Total Pages: 8
ISBN-13: 9240068139
DOWNLOAD EBOOKThis document is designed for medical practitioners and programme staff working in preventive chemotherapy programs using praziquantel or multiple doses of albendazole in areas endemic or potentially endemic for T. solium. The objective of this document is to facilitate the training and awareness creation on the early identification of neurological serious adverse events and its management at the health centres. This is a derivative document from the PAHO/WHO Guideline for preventive chemotherapy for the control of T. solium taeniasis https://www.who.int/publications/i/item/9789275123720). It is based on the WHO mhGAP (https://www.who.int/publications/i/item/9789241549790) and complements the WHO publication on ‘Safety in administering medicines for neglected tropical diseases’ (https://www.who.int/publications/i/item/9789240024144). A poster has also been developed to accompany this document.